nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multinational report on SARS-CoV-2 infection outcomes in people with CF and Aspergillus infection or ABPA
|
Bradbury, Jacob D. |
|
|
23 |
2 |
p. 354-363 |
artikel |
2 |
Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines
|
Shah, Kushal S. |
|
|
23 |
2 |
p. 300-305 |
artikel |
3 |
Can we decondition TRIKAFTA® tablets for the younger ones?
|
Gabsi, Asma |
|
|
23 |
2 |
p. 364-365 |
artikel |
4 |
Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location
|
Gold, Laura S. |
|
|
23 |
2 |
p. 278-281 |
artikel |
5 |
Chronic rhinosinusitis in people with CF, a rapidly changing field
|
Mainz, Jochen G. |
|
|
23 |
2 |
p. 183-184 |
artikel |
6 |
Chronic rhinosinusitis in the era of CFTR modulator therapy
|
Stone, Roy Gavin |
|
|
23 |
2 |
p. 208-213 |
artikel |
7 |
Effects of elexacaftor/tezacaftor/ivacaftor on liver fibrosis markers in adults with cystic fibrosis
|
Tewkesbury, Daniel H |
|
|
23 |
2 |
p. 349-353 |
artikel |
8 |
Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV1
|
Yanaz, Muruvvet |
|
|
23 |
2 |
p. 329-333 |
artikel |
9 |
Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftor
|
Wucherpfennig, Lena |
|
|
23 |
2 |
p. 234-241 |
artikel |
10 |
Elexacaftor/Tezacaftor/Ivacaftor therapy in cystic fibrosis children previously CFSPID: Is it over-medicalization?
|
Terlizzi, V. |
|
|
23 |
2 |
p. 366-367 |
artikel |
11 |
Frequent microbiological surveillance during inpatient cystic fibrosis pulmonary exacerbations has limited clinical value
|
Song, Wendy HC |
|
|
23 |
2 |
p. 282-287 |
artikel |
12 |
Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada
|
Zampoli, Marco |
|
|
23 |
2 |
p. 334-340 |
artikel |
13 |
Identification of prognostic biomarkers for antibiotic associated nephrotoxicity in cystic fibrosis
|
Hart, Andrew |
|
|
23 |
2 |
p. 293-299 |
artikel |
14 |
Impact of highly effective modulator therapy on chronic rhinosinusitis and health status: 2-year follow-up
|
Beswick, Daniel M. |
|
|
23 |
2 |
p. 214-218 |
artikel |
15 |
Influence of highly effective modulator therapy on the sputum proteome in cystic fibrosis
|
Maher, Rosemary E |
|
|
23 |
2 |
p. 269-277 |
artikel |
16 |
Innovation in care closer to home for people with cystic fibrosis: The importance of evaluating and collaborating
|
Daniels, Tracey E |
|
|
23 |
2 |
p. 181-182 |
artikel |
17 |
Letter to the editor: A contemporary assessment of CFTR modulator use and eligibility
|
Rubin, Jaime L. |
|
|
23 |
2 |
p. 368-369 |
artikel |
18 |
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
|
Einarsson, Gisli G. |
|
|
23 |
2 |
p. 252-261 |
artikel |
19 |
Modelling the spread of cystic fibrosis in Brittany using genealogical data over five centuries
|
Pellen, Nadine |
|
|
23 |
2 |
p. 341-348 |
artikel |
20 |
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
|
Gramegna, Andrea |
|
|
23 |
2 |
p. 306-313 |
artikel |
21 |
Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosis
|
Kopp, Benjamin T. |
|
|
23 |
2 |
p. 219-225 |
artikel |
22 |
Nasal lavage microbiome, but not nasal swab microbiome, correlates with sinonasal inflammation in children with cystic fibrosis
|
Chung, Jaehi |
|
|
23 |
2 |
p. 226-233 |
artikel |
23 |
News article
|
Balfour-Lynn, Ian |
|
|
23 |
2 |
p. 179-180 |
artikel |
24 |
Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population
|
Malhotra, Sankalp |
|
|
23 |
2 |
p. 314-320 |
artikel |
25 |
Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes
|
Thornton, Christina S. |
|
|
23 |
2 |
p. 321-328 |
artikel |
26 |
SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis
|
Ben-Meir, E. |
|
|
23 |
2 |
p. 288-292 |
artikel |
27 |
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
|
Burgel, Pierre-Régis |
|
|
23 |
2 |
p. 187-202 |
artikel |
28 |
The evolving focus of cystic fibrosis microbiome research
|
Taylor, Steven L. |
|
|
23 |
2 |
p. 185-186 |
artikel |
29 |
The gut microbiota in adults with cystic fibrosis compared to colorectal cancer
|
Caley, L.R. |
|
|
23 |
2 |
p. 262-268 |
artikel |
30 |
The relationship between the intestinal microbiome and body mass index in children with cystic fibrosis
|
Bernard, Rachel |
|
|
23 |
2 |
p. 242-251 |
artikel |
31 |
Year in review 2023 – Back to the future
|
Cristiani, Luca |
|
|
23 |
2 |
p. 203-207 |
artikel |